Compare Adaptive Biotechnologies Corp (ADPT) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs United Airlines Holdings Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while United Airlines Holdings Inc trades at $126.93 (market cap $41.00B). The key difference: United Airlines Holdings Inc is far larger — about 10.1× Adaptive Biotechnologies Corp's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | UAL | |
|---|---|---|
Market Cap | $4.04B | $41.00B |
Sector | Health | Industrials |
52-Week High | $25.45 | $136.11 |
52-Week Low | $12.30 | $85.21 |
Enterprise Value | $4.10B | $58.03B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
